Kimberly Robeson

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody–Positive Myasthenia Gravis

Kimberly Robeson, Aditya Kumar, Benison Keung et al. · JAMA Neurology · 2016 · 97 citations · Full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Metabolic Environment in Substantia Nigra Reticulata Is Critical for the Expression and Control of Hypoglycemia-Induced Seizures

Libor Velı́šek, Jana Velı́šková, Ondřej Chudomel et al. · Journal of Neuroscience · 2008 · 41 citations · Full text

Snr Neurons, Snr Expression, Neurotransmission +19

Serotonin modulation of cerebral glucose metabolism in normal aging

Sara Goldberg, Gwenn S. Smith, Anna Barnes et al. · Neurobiology of Aging · 2003 · 38 citations

Aging, Neurophysiology, Dementia +6